Exane Derivatives’s Baker Hughes BKR Stock Holding History

Exane Derivatives’s Portfolio BKR Stock Details BKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$318K	Sell	11,021 -13,929	-56%	-$471K	0.18%	128
2022 Q1	$908K	Buy	24,950 +12,422	+99%	+$377K	0.26%	103
2021 Q4	$301K	Buy	12,528 +12,517	+113,791%	+$309K	0.07%	262
2021 Q3	$272	Hold	11	–	–	﹤0.01%	994
2021 Q2	$246	Sell	11 -490	-98%	-$11.3K	﹤0.01%	1006
2021 Q1	$10.8K	Buy	+501	New	+$11.4K	﹤0.01%	594
2019 Q3	–	Sell	-4,198	Closed	-$103K	–	661
2019 Q2	$103K	Sell	4,198 -16,752	-80%	-$404K	0.02%	327
2019 Q1	$581K	Buy	20,950 +1,988	+10%	+$50.3K	0.11%	145
2018 Q4	$408K	Buy	18,962 +3,955	+26%	+$101K	0.07%	196
2018 Q3	$515K	Buy	15,007 +13,476	+880%	+$446K	0.1%	160
2018 Q2	$50.9K	Hold	1,531	–	–	0.01%	385
2018 Q1	$43.3K	Hold	1,531	–	–	0.01%	360
2017 Q4	$48.5K	Hold	1,531	–	–	0.01%	343
2017 Q3	$56.1K	Buy	+1,531	New	+$54.3K	0.01%	299

Other funds holding BKR

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Exane Derivatives's BKR Position: Q2 2022 in Review

Exane Derivatives reduced its Baker Hughes (BKR) stake by 56% in Q2 2022, selling an estimated $471K and leaving 11,021 shares worth $318K. The position accounts for 0.18% of the portfolio, ranked #128.

Exane Derivatives first reported a position in BKR in Q3 2017 and has held it in 14 quarters since. The position peaked at $908K in Q1 2022. 661 funds tracked by Wall St. Rank hold BKR as of Q2 2022.

Exane Derivatives held 11,021 shares of Baker Hughes worth $318K as of Q2 2022.
Exane Derivatives sold 13,929 Baker Hughes shares in Q2 2022, an estimated $471K.
Baker Hughes made up 0.18% of Exane Derivatives's portfolio in Q2 2022, its #128 holding.
Exane Derivatives first reported a position in Baker Hughes in Q3 2017 and has held it in 14 quarters since.
Exane Derivatives's Baker Hughes position peaked at $908K in Q1 2022.
661 funds tracked by Wall St. Rank held Baker Hughes as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.